Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

[MUSIC PLAYING] RANDALL TRUDELL: So the important thing with multiple sclerosis is initiating early treatment to prevent more trouble. We're not very good at fixing trouble. We're very good at ...

When it comes to the outlook for multiple sclerosis (MS), there’s both good ... with MS will undergo a certain amount of disease progression. To help determine your personal outlook, it helps ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April – – Reported Positive Outcome from Interim Analysis of Ongoing ...

Here’s what a new study concluded. In patients with multiple sclerosis, progression independent of relapse activity (PIRA) is the main driver of accumulation of disability and is associated with ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Patients presenting with a single neurologic event suggestive of multiple sclerosis (MS)—known as a clinically isolated syndrome—are at high risk of progression to clinically definite MS ...

Phenotypes collected include multiple system atrophy, progressive supranuclear palsy, multiple sclerosis, and brain tumors. The bank collects tissues and fluid from the entire brain and spinal cord, a ...